Studied for calm without the trade-offs that come with conventional anti-anxiety drugs.
If Semax is the stimulating end of the nootropic-peptide world, Selank is the calm one. It comes from the same Russian research tradition and is studied for a question a lot of people find compelling: can you influence anxiety pathways without the sedation and dependence that define benzodiazepines?
What it is
Selank is a synthetic heptapeptide (seven amino acids) based on a natural immune peptide called tuftsin, with modifications that make it more stable. Like Semax, it was developed to be brain-active without acting as a classical hormone.
What the research looks at
The dominant theme is anxiolytic — anti-anxiety — activity. The published research explores its effects on GABA and serotonin signalling (the same broad systems conventional anti-anxiety drugs target) and, like Semax, on BDNF. The interesting part is what the research doesn’t find: the sedation, tolerance and withdrawal associated with benzodiazepines don’t feature the same way, which is much of why it’s studied at all.
A calming effect without the usual baggage is a genuinely interesting research proposition — and the reason Selank has a following.
Where it sits
Selank and Semax are the two halves of the same story — calm and focus — and are frequently discussed together.
Handling in the lab
Lyophilised powder, reconstituted with bacteriostatic water and refrigerated once mixed. ≥99% HPLC purity, Janoshik verified — certificate on the product page.
In the catalogue
Selank
Stocked in our UK warehouse at ≥99% HPLC purity, Janoshik independently tested.
